Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Leukotriene Modulator Montelukast Alone or Combined With Inhaled Corticosteroid on Cough Variant Asthma.

Trial Profile

Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Leukotriene Modulator Montelukast Alone or Combined With Inhaled Corticosteroid on Cough Variant Asthma.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Montelukast (Primary) ; Budesonide/formoterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2013 Planned end date changed from 1 Apr 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
    • 16 Nov 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 08 Feb 2012 Planned End Date changed from 1 Dec 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top